182 related articles for article (PubMed ID: 36044391)
1. Absence of hyperfibrinolysis may explain lack of efficacy of tranexamic acid in hypoproliferative thrombocytopenia.
Ilich A; Gernsheimer TB; Triulzi DJ; Herren H; Brown SP; Holle LA; Lucas AT; de Laat B; El Kassar N; Wolberg AS; May S; Key NS
Blood Adv; 2023 Mar; 7(6):900-908. PubMed ID: 36044391
[TBL] [Abstract][Full Text] [Related]
2. Application of a plasmin generation assay to define pharmacodynamic effects of tranexamic acid in women undergoing cesarean delivery.
Miszta A; Ahmadzia HK; Luban NLC; Li S; Guo D; Holle LA; Berger JS; James AH; Gobburu JVS; van den Anker J; de Laat B; Wolberg AS
J Thromb Haemost; 2021 Jan; 19(1):221-232. PubMed ID: 33001565
[TBL] [Abstract][Full Text] [Related]
3. Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator-dependent manner.
Barrett CD; Moore HB; Kong YW; Chapman MP; Sriram G; Lim D; Moore EE; Yaffe MB
J Trauma Acute Care Surg; 2019 Jan; 86(1):101-107. PubMed ID: 30575685
[TBL] [Abstract][Full Text] [Related]
4. Increased urokinase and consumption of α
Longstaff C; Locke M
J Thromb Haemost; 2019 Jan; 17(1):195-205. PubMed ID: 30451372
[TBL] [Abstract][Full Text] [Related]
5. Tranexamic acid rapidly inhibits fibrinolysis, yet transiently enhances plasmin generation in vivo.
Draxler DF; Zahra S; Goncalves I; Tran H; Hanafi G; Ho H; Keragala CB; Ilich A; Key NS; Myles PS; Medcalf RL
Blood Coagul Fibrinolysis; 2021 Apr; 32(3):172-179. PubMed ID: 33443933
[TBL] [Abstract][Full Text] [Related]
6. Plasmin thrombelastography rapidly identifies trauma patients at risk for massive transfusion, mortality, and hyperfibrinolysis: A diagnostic tool to resolve an international debate on tranexamic acid?
Barrett CD; Moore HB; Vigneshwar N; Dhara S; Chandler J; Chapman MP; Sauaia A; Moore EE; Yaffe MB
J Trauma Acute Care Surg; 2020 Dec; 89(6):991-998. PubMed ID: 33230046
[TBL] [Abstract][Full Text] [Related]
7. Synergism of red blood cells and tranexamic acid in the inhibition of fibrinolysis.
Raska A; Kálmán K; Egri B; Csikós P; Beinrohr L; Szabó L; Tenekedjiev K; Nikolova N; Longstaff C; Roberts I; Kolev K; Wohner N
J Thromb Haemost; 2024 Mar; 22(3):794-804. PubMed ID: 38016517
[TBL] [Abstract][Full Text] [Related]
8. Tranexamic acid: Beyond antifibrinolysis.
Prudovsky I; Kacer D; Zucco VV; Palmeri M; Falank C; Kramer R; Carter D; Rappold J
Transfusion; 2022 Aug; 62 Suppl 1():S301-S312. PubMed ID: 35834488
[TBL] [Abstract][Full Text] [Related]
9. Point-of-care testing for tranexamic acid efficacy: a proof-of-concept study in cardiac surgical patients.
Yoshii R; Takahashi Y; Tanaka KA; Kawajiri H; Sawa T; Amaya F; Ogawa S
Br J Anaesth; 2024 Jun; 132(6):1211-1218. PubMed ID: 38677950
[TBL] [Abstract][Full Text] [Related]
10. Effective tranexamic acid concentration for 95% inhibition of tissue-type plasminogen activator induced hyperfibrinolysis in children with congenital heart disease: A prospective, controlled, in-vitro study.
Rozen L; Faraoni D; Sanchez Torres C; Willems A; Noubouossie DC; Barglazan D; Van der Linden P; Demulder A
Eur J Anaesthesiol; 2015 Dec; 32(12):844-50. PubMed ID: 26258658
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the in-vivo effect of two tranexamic acid doses on fibrinolysis parameters in adults undergoing valvular cardiac surgery with cardiopulmonary bypass - a pilot investigation.
Zhou ZF; Zhai W; Yu LN; Sun K; Sun LH; Xing XF; Yan M
BMC Anesthesiol; 2021 Feb; 21(1):33. PubMed ID: 33530942
[TBL] [Abstract][Full Text] [Related]
12. Clot lysis time in platelet-rich plasma: method assessment, comparison with assays in platelet-free and platelet-poor plasmas, and response to tranexamic acid.
Panes O; Padilla O; Matus V; Sáez CG; Berkovits A; Pereira J; Mezzano D
Platelets; 2012; 23(1):36-44. PubMed ID: 21787173
[TBL] [Abstract][Full Text] [Related]
13. An in vitro study of the effects of t-PA and tranexamic acid on whole blood coagulation and fibrinolysis.
Godier A; Parmar K; Manandhar K; Hunt BJ
J Clin Pathol; 2017 Feb; 70(2):154-161. PubMed ID: 27445340
[TBL] [Abstract][Full Text] [Related]
14. Does Tranexamic Acid Improve Clot Strength in Severely Injured Patients Who Have Elevated Fibrin Degradation Products and Low Fibrinolytic Activity, Measured by Thrombelastography?
Moore HB; Moore EE; Chapman MP; Hansen KC; Cohen MJ; Pieracci FM; Chandler J; Sauaia A
J Am Coll Surg; 2019 Jul; 229(1):92-101. PubMed ID: 30936005
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of primary hyperfibrinolysis and in vitro investigation of the inhibitory effects of tranexamic acid in a group of dogs with sarcomas - A pilot study.
Langhorn R; Poulsen MK; Heidemann PL; Bochsen L; Ritz C; Kristensen AT; Nielsen LN
Res Vet Sci; 2021 May; 136():472-477. PubMed ID: 33838456
[TBL] [Abstract][Full Text] [Related]
16. Tranexamic acid administration in the field does not affect admission thromboelastography after traumatic brain injury.
Dixon AL; McCully BH; Rick EA; Dewey E; Farrell DH; Morrison LJ; McMullan J; Robinson BRH; Callum J; Tibbs B; Dries DJ; Jui J; Gandhi RR; Garrett JS; Weisfeldt ML; Wade CE; Aufderheide TP; Frascone RJ; Tallon JM; Kannas D; Williams C; Rowell SE; Schreiber MA
J Trauma Acute Care Surg; 2020 Nov; 89(5):900-907. PubMed ID: 33105308
[TBL] [Abstract][Full Text] [Related]
17. Effective tranexamic acid concentration for 95% inhibition of tissue-type plasminogen activator-induced hyperfibrinolysis in full-term pregnant women: a prospective interventional study.
Lechien A; Faraoni D; Van der Linden P
Blood Coagul Fibrinolysis; 2021 Apr; 32(3):186-193. PubMed ID: 33470644
[TBL] [Abstract][Full Text] [Related]
18. Tranexamic acid leads to paradoxical coagulation changes during cardiac surgery: a pilot rotational thromboelastometry study.
Sharma R; Letson HL; Smith S; Dobson GP
J Surg Res; 2017 Sep; 217():100-112. PubMed ID: 28602219
[TBL] [Abstract][Full Text] [Related]
19. Intramuscular administration of tranexamic acid in a large swine model of hemorrhage with hyperfibrinolysis.
Haberkorn CJ; Severance CC; Wetmore NC; West WG; Ng PC; Cendali F; Pitotti C; Schauer SG; Maddry JK; Bebarta VS; Hendry-Hofer TB
J Trauma Acute Care Surg; 2024 May; 96(5):735-741. PubMed ID: 37962201
[TBL] [Abstract][Full Text] [Related]
20. Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders.
Wardrop D; Estcourt LJ; Brunskill SJ; Doree C; Trivella M; Stanworth S; Murphy MF
Cochrane Database Syst Rev; 2013 Jul; (7):CD009733. PubMed ID: 23897323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]